기준가
$87.78
운용 규모
$127.3M
보수율
-
배당수익률
0.06%
베타
1.25
통화
USD
| YTD | 1개월 | 3개월 | 1년 | 3년 | 5년 |
|---|---|---|---|---|---|
| -0.42% | +8.71% | +12.32% | +7.34% | -3.28% | -7.34% |
| 순위 | 종목코드 | 종목명 | 비중 |
|---|---|---|---|
| 1 | STAA | Staar Surgical Co | 2.95% |
| 2 | NVCR | NovoCure Ltd | 2.36% |
| 3 | IART | Integra Lifesciences Holdings Corp | 2.15% |
| 4 | AXGN | Axogen Inc | 2.13% |
| 5 | AVNS | Avanos Medical Inc | 2.10% |
| 6 | LNTH | Lantheus Holdings Inc | 2.10% |
| 7 | BFLY | Butterfly Network Inc Ordinary Shares - Class A | 2.07% |
| 8 | LIVN | LivaNova PLC | 2.06% |
| 9 | OMCL | Omnicell Inc | 2.06% |
| 10 | TFX | Teleflex Inc | 2.00% |
In seeking to track the performance of the S&P Health Care Equipment Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care equipment segment of the S&P Total Market Index ("S&P TMI").
설정일: 2011-01-26